Contract Pharma | Pharma Matters Q&A interview with our CEO, Jarlath Keating
A conversation with Jarlath Keating, CEO of Phosphorex, on the future of LNPs in pharmaceutical innovation.
In recent years, lipid nanoparticles (LNPs) have emerged as a groundbreaking technology in the pharmaceutical world, revolutionizing the delivery of complex therapeutic molecules like RNA and DNA.
Covering Cutting-Edge Scientific and Business Trends in Drug Delivery
Pharma, biotech and drug delivery industries gathered at the 14th annual PODD event to assess delivery needs, information on deals and and latest trends in innovative drug delivery technologies. This included small molecules, biologics, combination products, connected devices, cell and gene delivery and more.
PODD provided partnering opportunities through organized networking for new, emerging and established collaborations.
Discovery and Basic Research
Basic research advances fundamental knowledge and predictions that form the scientific foundation for progress in applied science. Discovery research leads to new scientific ideas, theories, applications, and ways of thinking that form the basis of growth and development in different fields. Generating this critical knowledge is the first step toward inventing new tools, sparking therapeutic innovation, and enabling a more rapid and successful delivery of novel drugs to the market.
Press Announcement: Phosphorex and NOF Corporation launches Innovation and Training Center in Hopkington, MA....